Bare metal stent thrombosis 13 years after implantation

☆ Disclosures: Dr. Bhatt discloses the following relationships: Research Grants (directly to the institution) - Bristol Myers Squibb, Eisai, Ethicon, Sanofi Aventis, The Medicines Company; Honoraria (currently donated to non-profits) – Astra Zeneca, Bristol Myers Squibb, Centocor, Daiichi- Sankyo, Eisai, Eli Lilly, Glaxo Smith Kline, Millennium, Paringenix, PDL, Sanofi Aventis, Schering Plough, The Medicines Company, tns Healthcare; Speaker’s bureau (not current, over 2 years ago) – Bristol Myers Squibb, Sanofi Aventis, The Medicines Company; Consultant/Advisory Board (currently donated to non-profits) – Astra Zeneca, Bristol Myers Squibb, Cardax, Centocor, Cogentus, Daiichi-Sankyo, Eisai, Eli Lilly, Glaxo Smith Kline, Johnson & Johnson, McNeil, Medtronic, Millennium, Otsuka, Paringenix, PDL, Philips, Portola, Sanofi Aventis, Schering Plough, The Medicines Company, tns Healthcare, Vertex; Expert testimony regarding clopidogrel (the compensation was donated to a non-profit organization); Cleveland Clinic Coordinating Center currently receives or has received research funding from: Abraxis, Alexion Pharma, AstraZeneca, Atherogenics, Aventis, Biosense Webster, Biosite, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardionet, Centocor, Converge Medical Inc., Cordis, Dr. Reddy’s, Edwards Lifesciences, Esperion, GE Medical, Genentech, Gilford, GSK, Guidant, J&J, Kensey-Nash, Lilly, Medtronic, Merck, Mytogen, Novartis, Novo Nordisk, Orphan Therapeutics, P&G Pharma, Pfizer, Roche, Sankyo, Sanofi-Aventis, Schering-Plough, Scios, St. Jude Medical, Takeda, TMC, VasoGenix, Viacor. Dr. Bavry discloses the following: honoraria for consulting from The Frankel Group, Boston Scientific, Propagate Pharma, HRA, Marketing Research Services of Houston, Medical Marketing Conference, Hagen/Sinclair Research Recruiting, and KCI Partners.

PII: S1553-8389(08)00207-8

doi: 10.1016/j.carrev.2008.04.003

© 2009 Elsevier Inc. All rights reserved.